Skip to content
10-K

Annual Report

Yubo International Biotech Ltd YBGJ

0001640334-25-000547

← back to feed
Filed
Mar 31, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Mar 31, 2025 119.82M sh
Cash And Equivalents FY 2024 · Dec 31, 2024 $7.02K
Shares Diluted FY 2024 · Dec 31, 2023 11.98M sh
Operating Cash Flow FY 2024 · Dec 31, 2023 −$738.97K
Stockholders Equity FY 2024 · Dec 31, 2023 −$1.84M
Current Liabilities FY 2024 · Dec 31, 2023 $3.4M
Total Liabilities FY 2024 · Dec 31, 2023 $3.51M
Current Assets FY 2024 · Dec 31, 2023 $725.24K
Total Assets FY 2024 · Dec 31, 2023 $1.67M
Eps Diluted FY 2024 · Dec 31, 2023 −$0.10
Net Income FY 2024 · Dec 31, 2023 −$1.2M
Operating Income FY 2024 · Dec 31, 2023 −$1.19M
Gross Profit FY 2024 · Dec 31, 2023 $419.19K
Cost Of Revenue FY 2024 · Dec 31, 2023 $185.49K
Revenue FY 2024 · Dec 31, 2023 $604.68K